A platform for glycoengineering a polyvalent pneumococcal bioconjugate vaccine using E. coli as a host.
Harding CM, Nasr MA, Scott NE, Goyette-Desjardins G, Nothaft H, Mayer AE, Chavez SM, Huynh JP, Kinsella RL, Szymanski CM, Stallings CL, Segura M, Feldman MF.
Harding CM, et al. Among authors: kinsella rl.
Nat Commun. 2019 Feb 21;10(1):891. doi: 10.1038/s41467-019-08869-9.
Nat Commun. 2019.
PMID: 30792408
Free PMC article.